Case Details
- Citation: [2008] SGHC 165
- Title: Wing Hak Man and Another v Bio-Treat Technology Ltd and Others
- Court: High Court of the Republic of Singapore
- Date of Decision: 29 September 2008
- Judge: Belinda Ang Saw Ean J
- Case Numbers: Suit 682/2007; RA 11/2008; SUM 94/2008; 280/2008
- Coram: Belinda Ang Saw Ean J
- Plaintiffs/Applicants: Wing Hak Man; Yiu Ching
- Defendants/Respondents: Bio-Treat Technology Ltd (first defendant); Jerry Yip Wai Leung (second defendant); Dennis Chan Kong (third defendant); Kwok Chi-Shing (fourth defendant)
- Legal Areas: Civil Procedure (stay of proceedings; forum non conveniens); Conflict of Laws (natural forum)
- Procedural Posture: The plaintiffs’ appeal against a stay order was dismissed; separate stay applications by the second and fourth defendants were allowed, with related procedural directions on late filing of a summons.
- Key Procedural Facts: The second defendant was called upon to file a defence within 48 hours after the first defendant obtained a stay; the second defendant filed a holding defence containing a reservation of rights to apply for a stay. A summons filed late in contravention of O 12 r 7(2) of the Rules of Court was nevertheless allowed out of time.
- Substantive Claim: Unlawful means conspiracy alleging fraudulent misrepresentations and other unlawful acts to deprive the plaintiffs of shares in a Singapore-listed company managed from Hong Kong.
- Relief Sought (in substance): The plaintiffs sought to proceed with their conspiracy claim in Singapore against multiple directors/defendants.
- Outcome: Stay of proceedings granted against the second and fourth defendants; costs ordered in favour of Bio-Treat, the second defendant, and the fourth defendant (as reflected in the judgment extract).
- Counsel: Adrian Tan and Wendell Wong (Drew & Napier LLC) for the plaintiff; Edwin Tong and Aaron Lee (Allen & Gledhill LLP) for the first defendant; Devinder K Rai (Acies Law Corporation) for the second defendant; Rajendran Kumaresan (Central Chambers Law Corporation) for the fourth defendant.
- Statutes Referenced: Companies Act; Securities and Futures Act; Rules of Court (Cap 322, R 5, 2006 Rev Ed) including O 12 r 7(2).
- Noted Regulatory Context (from metadata): The judgment references that Singapore was to avoid prosecution under the Securities and Futures Act (as indicated in the metadata provided).
- Cases Cited: [2004] SGHC 115; [2008] SGCA 34; [2008] SGHC 165 (the latter being the present case as cited in the metadata).
- Judgment Length: 17 pages; 10,352 words (as provided in metadata).
Summary
Wing Hak Man and Another v Bio-Treat Technology Ltd and Others [2008] SGHC 165 concerns an application for a stay of proceedings in a Singapore action pleaded as an unlawful means conspiracy. The plaintiffs, Wing Hak Man and Yiu Ching, alleged that the defendants conspired to deprive them of shares in Bio-Treat Technology Ltd, a company incorporated in Bermuda but listed and traded on the Singapore Exchange. Although the shares were traded in Singapore, the plaintiffs’ pleaded case was that the company’s management and key conduct were carried out from Hong Kong, and that the alleged conspiratorial acts were orchestrated through complex offshore structures.
The first defendant (Bio-Treat) had already obtained a stay on forum non conveniens grounds. The plaintiffs appealed, but the appeal was dismissed. Separately, the second and fourth defendants applied for their own stays. The court allowed those stay applications. A further procedural issue arose because the second defendant’s summons was filed late, and the plaintiffs argued that the second defendant’s filing of a holding defence after the first defendant’s stay order compromised or undermined the second defendant’s ability to pursue its own stay application.
What Were the Facts of This Case?
The plaintiffs’ dispute is rooted in their alleged loss of substantial shareholdings in Bio-Treat. Wing was the founder of Bio-Treat and held significant interests through a BVI holding company structure. Specifically, Wing was the sole owner of Fullway Group Limited (“Fullway”), a company incorporated in the British Virgin Islands (BVI), which held 289,050,000 ordinary shares (37.39%) in Bio-Treat. Yiu, Wing’s wife, was the sole owner of Star Choice International Limited (“Star Choice”), also incorporated in the BVI, which held 39,808,000 ordinary shares (5.15%) in Bio-Treat.
Bio-Treat was incorporated in Bermuda on 22 August 2003 and listed on the Main Board of the Singapore Stock Exchange Securities Trading Limited on 16 February 2004. While the shares were traded in Singapore, the business and operations were said to be wholly in the People’s Republic of China. The plaintiffs’ pleading further alleged that Bio-Treat was managed from Hong Kong by other defendants. At the material times, Wing was based in Bio-Treat’s Shanghai office. The second defendant, Jerry Yip Wai Leung (“D2”), was an independent director and a lawyer by profession, serving on committees until his resignation on 31 July 2007. The fourth defendant, Kwok Chi-Shing (“D4”), was an independent director and an accountant, serving as chairman of the audit committee and also on nominating and remuneration committees.
The plaintiffs’ substantive claim was framed as a conspiracy by unlawful means. They alleged that the defendants conspired to injure them by fraudulent misrepresentations and other unlawful acts, which caused them damage said to exceed S$400 million. The alleged conspiracy was described as an ongoing overall conspiracy joined by various defendants at unspecified times between May 2005 and September 2007. The pleaded unlawful acts included (i) the incorporation of a web of BVI companies as conduits for fraudulent transfer or divestment of the plaintiffs’ shares; (ii) allegations that the defendants wrongfully and dishonestly wrested control of the plaintiffs’ shares by fraudulently transferring them to other BVI companies and selling them, and/or fraudulently transferring the shares in the open market and then to a PRC entity (Dongguan Baosheng Environmental Investment Co Ltd) through another BVI company (Precious Wise Group Limited); (iii) allegations that false and/or misleading announcements were lodged on the Singapore Stock Exchange to mislead the general public; (iv) allegations that Wing was fraudulently induced to “sell” some shares to pay compensation to key employees affected by a cancelled option programme; and (v) allegations that Wing’s resignation as executive/non-executive chairman and executive director was fabricated or orchestrated to impede his ability to investigate the share transfers.
A central episode in the plaintiffs’ case concerned the alleged setting up of a trust known as the Wing Family Trust. The trustee was a New Zealand company, Wing Enterprise Trustee Company Limited. The plaintiffs alleged that D2 raised the idea of setting up a family trust to hold the plaintiffs’ Bio-Treat shares for Wing and his family, and that Wing signed documents in Hong Kong around 7 May 2005 relying on D2 and on a company secretary (Tan Siok Chin) who allegedly translated and interpreted the documents. The plaintiffs alleged that Wing later learned from an SGX announcement dated 9 May 2005 that the trust had been set up, and that D2 had represented that Yiu’s signature was required for execution, yet Yiu claimed she did not sign any documents relating to the trust.
According to the plaintiffs, the trust and associated BVI corporate entities were used to facilitate fraudulent transfers. Wing purportedly gave up the issued capital of Fullway to Energy Castle Limited, and Yiu purportedly gave up the issued capital of Star Choice to Herofaith Limited, with further layers through Key Advance Limited and other entities. The plaintiffs’ case was that Yiu’s signature was forged or tampered with, or that Wing was fraudulently misled into believing both signatures were required. Wing also claimed that his signature on a notice of substantial shareholding interests/change in interests/cessation of interests dated 7 May 2005 was forged or tampered with.
What Were the Key Legal Issues?
The decision addresses both procedural and conflict-of-laws questions. First, there was the procedural issue of whether the second defendant’s conduct—specifically, filing a defence after the first defendant obtained a stay—compromised the second defendant’s ability to apply for a stay. After Bio-Treat’s lawyers called upon D2 to file his defence within 48 hours on pain of default judgment, D2 filed a defence on 11 January 2008. That defence was described as a holding defence containing a reservation of the right to apply for a stay. The plaintiffs argued that this step amounted to an acceptance of Singapore as the forum or otherwise undermined the stay application.
Second, the court had to determine the conflict-of-laws issue: whether Singapore or Hong Kong was the natural forum for the dispute. The plaintiffs alleged that the conspiracy involved unlawful acts including fraudulent misrepresentations, false SGX announcements, and offshore corporate transfers. However, the plaintiffs’ own pleaded narrative emphasised that management and key conduct were carried out from Hong Kong, and that the alleged conspiratorial acts were connected to events and documents in Hong Kong and offshore jurisdictions. The court therefore had to assess forum non conveniens and decide whether the proceedings should be stayed in Singapore in favour of Hong Kong.
Third, although the case is primarily about stay, the court also considered the nature of the pleaded conspiracy claim—particularly the requirement that unlawful means conspiracy requires concerted action and sufficient awareness of the surrounding circumstances and shared objective. This analysis mattered because it informed the practical assessment of where evidence and witnesses would be located and where the real dispute would be adjudicated.
How Did the Court Analyse the Issues?
The court began by characterising the substance of the claim. The plaintiffs’ action was “quite clearly pleaded” as an unlawful means conspiracy. The foundation was that the defendants conspired to injure the plaintiffs by unlawful means, namely fraudulent misrepresentations, and that those misrepresentations caused damage. The court noted that the unlawful acts were pleaded as an ongoing overall conspiracy joined by various defendants at unspecified times. This framing required the court to examine whether the pleaded conspiracy alleged sufficient concerted action by the defendants, rather than merely a series of independent acts.
In discussing the conspiracy framework, the court emphasised that even if a party may join in execution at different times and may not know precisely what other conspirators agreed to do, liability for conspiracy still requires that the party be sufficiently aware of the surrounding circumstances and share the same objective as the others. The court cited OCM Opportunities Fund II, LP and others v Burhan Uray (alias Wong Ming Kong) and Others [2004] SGHC 115 at [49] (“OCM Opportunities”) for this proposition. The shared objective in the pleadings was to deprive the plaintiffs of their shares in Bio-Treat and the proceeds from related sales. The court also observed that the pleaded unlawful acts were detailed and varied, including offshore corporate structuring and alleged misleading announcements.
Turning to the procedural issue, the court addressed the plaintiffs’ argument that D2’s filing of a defence compromised his stay application. The court explained that Bio-Treat’s lawyers had called upon D2 to file his defence within 48 hours, failing which default judgment would be obtained. D2 filed his defence on 11 January 2008. Importantly, the defence was described as a holding defence with a reservation of rights to apply for a stay. The court treated this as a pragmatic procedural response to avoid default, rather than a substantive submission to the jurisdiction. In other words, the court did not view the holding defence as inconsistent with pursuing a stay, especially where the stay was already being sought and where the filing was compelled by procedural deadlines.
Additionally, the court dealt with the late filing of the second defendant’s summons. Summons No 94 of 2008 was filed late in contravention of O 12 r 7(2) of the Rules of Court. The court nonetheless exercised its discretion to grant leave to file out of time after considering the overall facts and circumstances. This reinforced the court’s approach: procedural steps taken under pressure of default timelines should not be treated as waivers of substantive procedural rights, particularly where the underlying application is timely in substance and where the court can be satisfied that no prejudice arises that would justify refusing leave.
On the conflict-of-laws question, the court’s reasoning is consistent with the earlier stay order obtained by Bio-Treat and the dismissal of the plaintiffs’ appeal. Although the extract provided does not reproduce the full forum non conveniens analysis, the judgment’s structure indicates that the court assessed the natural forum by reference to the location of management, the locus of alleged conspiratorial conduct, and the practicalities of evidence and witnesses. The plaintiffs alleged that Bio-Treat was managed from Hong Kong and that the defendants’ conduct—such as the trust-related events in Hong Kong and the orchestration of offshore transfers—had strong connections to Hong Kong. The court therefore concluded that Hong Kong was the natural forum for adjudicating the dispute, notwithstanding that the shares were traded in Singapore and that some alleged unlawful acts involved SGX announcements.
The court’s approach also reflects an understanding that forum non conveniens analysis is not purely formal. Even where Singapore has a connection (such as listing and trading), the court will consider where the real contest lies. In conspiracy by unlawful means cases involving complex offshore structures and cross-border conduct, the location of key documents, witnesses, and the factual substratum often points to the jurisdiction where the alleged orchestration occurred. The court’s decision to stay proceedings against D2 and D4 aligns with that practical assessment.
What Was the Outcome?
The court allowed the stay applications brought by the second and fourth defendants. It ordered a stay of all further proceedings in the action against D2 and D4. This meant that, as against those defendants, the plaintiffs could not continue the Singapore action and would have to pursue their claims in the natural forum identified by the court.
In addition, the court made costs orders in favour of Bio-Treat, D2, and D4 respectively. The practical effect was twofold: first, the litigation in Singapore was halted against the relevant defendants; second, the court’s discretionary approach to procedural compliance (including leave to file out of time) ensured that the stay applications were not defeated by technical procedural timing issues.
Why Does This Case Matter?
This case is significant for practitioners because it illustrates how Singapore courts handle stay applications in complex cross-border disputes, particularly where the claim is pleaded as an unlawful means conspiracy. The decision underscores that the court will look beyond the existence of Singapore connections such as listing and trading, and will focus on where the dispute’s factual core and evidential burdens realistically lie. For litigators, this is a reminder that forum non conveniens arguments can succeed even when the alleged unlawful conduct includes elements that touch Singapore markets.
Wing Hak Man also provides practical guidance on procedural conduct in the context of stay applications. The court accepted that a holding defence filed to avoid default—while reserving rights to seek a stay—does not necessarily amount to a waiver of the stay position. This is particularly relevant for defendants who face strict procedural timelines after a co-defendant obtains a stay. The decision supports the view that protective procedural steps taken under threat of default should not be treated as inconsistent with pursuing a stay.
Finally, the case’s discussion of the elements of unlawful means conspiracy—especially the requirement of sufficient awareness and shared objective—can be useful in stay-related reasoning. While the court is not finally determining liability at the stay stage, the nature of the pleaded conspiracy affects the assessment of what evidence will be required and where witnesses and documents are likely to be located. Lawyers should therefore carefully plead and analyse conspiracy allegations, because the way the claim is framed can influence both the forum assessment and the litigation strategy.
Legislation Referenced
- Companies Act (including references to the J of the Companies Act as indicated in the metadata)
- Securities and Futures Act
- Rules of Court (Cap 322, R 5, 2006 Rev Ed), in particular O 12 r 7(2)
Cases Cited
- [2004] SGHC 115 (OCM Opportunities Fund II, LP and others v Burhan Uray (alias Wong Ming Kong) and Others)
- [2008] SGCA 34
- [2008] SGHC 165 (Wing Hak Man and Another v Bio-Treat Technology Ltd and Others)
Source Documents
This article analyses [2008] SGHC 165 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.